Sign In
Buy BDX
$170.66
+0.540 (+0.317%)
At Close: Aug 05, 2026
4 Overlooked Dividend Aristocrat Stocks with Up To 60%+ Growth Potential
07:07am, Sunday, 10'th Aug 2025
Dividend Aristocrat stocks are a select group of 69 stocks that have an unbroken track record of at least 25 consecutive years of dividend increases.
BD Stock Gains in Pre-Market Following Q3 Earnings Beat, Margins Up
12:06pm, Thursday, 07'th Aug 2025
BDX tops third-quarter fiscal 2025 earnings and margin estimates, with strong results from its Medical and Interventional segments.
Becton Dickinson Q3 Beats Estimates On Medical Device Boom
11:40am, Thursday, 07'th Aug 2025
As the healthcare industry continues to rebound from global disruptions, companies like Becton, Dickinson, and Company BDX are reporting robust financial performances that highlight their resilience
Here's What Key Metrics Tell Us About Becton Dickinson (BDX) Q3 Earnings
10:31am, Thursday, 07'th Aug 2025
Although the revenue and EPS for Becton Dickinson (BDX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall
Becton, Dickinson and Company (BDX) Q3 2025 Earnings Call Transcript
09:51am, Thursday, 07'th Aug 2025
Becton, Dickinson and Company (NYSE:BDX ) Q3 2025 Earnings Call August 7, 2025 8:00 AM ET Company Participants Christopher J. DelOrefice - Executive VP & CFO Greg Rodetis - Senior VP, Treasurer & Head
Becton Dickinson (BDX) Surpasses Q3 Earnings and Revenue Estimates
08:40am, Thursday, 07'th Aug 2025
Becton Dickinson (BDX) came out with quarterly earnings of $3.68 per share, beating the Zacks Consensus Estimate of $3.42 per share. This compares to earnings of $3.5 per share a year ago.
Becton Dickinson joins peer in raising annual profit forecast after results beat
07:34am, Thursday, 07'th Aug 2025
Becton Dickinson raised its forecast for annual profit on Thursday, after beating Wall Street estimates for third-quarter profit and sales on strong demand for its drug-delivery devices.
BD Reports Third Quarter Fiscal 2025 Financial Results
06:30am, Thursday, 07'th Aug 2025
Revenue of $5.5 billion increased 10.4% as reported, 8.5% adjusted FXN and 3.0% organic GAAP and adjusted diluted EPS grew to $2.00 and $3.68, respectively GAAP and adjusted gross margin up 160 basis
Can Sustained Product Demand Drive BDX Stock Before Q3 Earnings?
01:21pm, Tuesday, 05'th Aug 2025
BD's third-quarter fiscal 2025 results are likely to benefit from product launches across Medical and Interventional segments, which drive strong revenue potential.
BD Businesses Become First in MedTech to Achieve HIRC's Diamond Badge Across All Supply Chain Resiliency Categories
06:50am, Tuesday, 05'th Aug 2025
FRANKLIN LAKES, N.J. , Aug. 5, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its Urology and Critical Care (UC
Curious about Becton Dickinson (BDX) Q3 Performance? Explore Wall Street Estimates for Key Metrics
10:16am, Monday, 04'th Aug 2025
Evaluate the expected performance of Becton Dickinson (BDX) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key met
BD to Invest $35 Million in Nebraska Facility to Expand Prefilled Flush Syringe Manufacturing to Support U.S. Health Care
06:50am, Monday, 04'th Aug 2025
FRANKLIN LAKES, N.J. , Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest more than $35 million
BD Aims to Save Lives by Empowering Women with Choice and Access to Cervical Cancer Screening Self-Collected At Home
04:15pm, Thursday, 31'st Jul 2025
New FDA Submission Includes Self-Collection Swab and High-Tech Laboratory Robotics that Report More High-Risk HPV Strains Than Any Other Test FRANKLIN LAKES, N.J. , July 31, 2025 /PRNewswire/ -- BD (B
Earnings Preview: Becton Dickinson (BDX) Q3 Earnings Expected to Decline
11:08am, Thursday, 31'st Jul 2025
Becton Dickinson (BDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BD Receives FDA 510(k) Clearance for Rapid Point-of-Care COVID-19 Test
06:50am, Wednesday, 30'th Jul 2025
New CLIA-Waived Test Delivers Digital Results to Support Timely Clinical Decision-Making FRANKLIN LAKES, N.J. , July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading
